secwatch.observer — SEC 8-K summary
======================================

Issuer:     Protagenic Therapeutics, Inc.new (PTIX)
CIK:        0001022899
Form:       8-K
Filed at:   2025-05-05T23:59:59+00:00
Accession:  0001641172-25-008455
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Protagenic Therapeutics effects 1-for-14 reverse stock split to meet Nasdaq bid price rule
--------------------------------------------------------------------------------

- Reverse stock split at 1-for-14 ratio effective 12:01 a.m. ET on May 5, 2025.
- Approved by stockholders at April 18, 2025 special meeting; board set ratio to comply with Nasdaq Rule 5550(a)(2).
- Common stock trades on Nasdaq under symbol PTIX with new CUSIP 74365N301; warrants continue under PTIXW.
- Fractional shares rounded up; proportionate adjustments to outstanding options, warrants, and RSUs.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1022899/000164117225008455/0001641172-25-008455-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1022899/000164117225008455/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-008455

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer